首页|华蟾素胶囊在晚期胃癌化疗患者中的应用效果

华蟾素胶囊在晚期胃癌化疗患者中的应用效果

扫码查看
目的 探讨华蟾素胶囊在晚期胃癌化疗患者中的应用效果.方法 根据治疗方式的不同将82例晚期胃癌化疗患者分为观察组(40例)和对照组(42例),对照组患者接受奥沙利铂+替吉奥(SOX)方案化疗,观察组患者在对照组的基础上接受华蟾素胶囊治疗.比较两组患者的临床疗效、肿瘤标志物[糖类抗原72-4(CA72-4)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)]、癌因性疼痛[视觉模拟评分法(VAS)]、生活质量[癌症患者生命质量测定量表(FACT-G)]及不良反应发生情况.结果 观察组患者的疾病控制率为42.50%,高于对照组患者的21.43%,差异有统计学意义(P﹤0.05).治疗后,两组患者CEA、CA19-9、CA72-4水平及VAS、FACT-G评分均低于本组治疗前,观察组患者CEA、CA19-9、CA72-4水平及VAS、FACT-G评分均低于对照组,差异均有统计学意义(P﹤0.05).两组患者各不良反应发生率比较,差异均无统计学意义(P﹥0.05).结论 华蟾素胶囊治疗晚期胃癌化疗患者疗效显著,可降低血清肿瘤标志物水平,减轻癌因性疼痛,提高生活质量,且不会增加不良反应.
Application effect of Huachansu capsule in patients with advanced gastric cancer undergoing chemotherapy
Objective To investigate the application effect of Huachansu capsule in patients with advanced gastric cancer undergoing chemotherapy.Method A total of 82 patients with advanced gastric cancer who underwent chemo-therapy were divided into observation group(40 cases)and control group(42 cases)according to different treatment meth-ods.The control group received oxaliplatin combined with S-1(SOX)regimen chemotherapy,and the observation group received Huachansu capsule therapy on the basis of the control group.The clinical efficacy,tumor marker[carbohydrate antigen 72-4(CA72-4),carcinoembryonic antigen(CEA),carbohydrate antigen 19-9(CA19-9)],cancer-related pain[visu-al analogue scale(VAS)],quality of life[functional assessment of cancer therapy-general(FACT-G)]and incidence of ad-verse reactions were compared between the two groups.Result The disease control rate of observation group was 42.50%,which was higher than 21.43%of control group,the difference was statistically significant(P<0.05).After treat-ment,the levels of CEA,CA19-9,CA72-4 and the scores of VAS,FACT-G in two groups were lower than those before treatment,the levels of CEA,CA19-9,CA72-4 and the scores of VAS,FACT-G in observation group were lower than those in control group,and the differences were statistically significant(P<0.05).There were no significant differences in the incidences of adverse reactions between the two groups(P>0.05).Conclusion The application of Huachansu capsule in patients with advanced gastric cancer undergoing chemotherapy is effective,can reduce the level of serum tumor mark-er,relieve cancer-related pain,improve quality of life,and does not increase adverse reaction.

advanced gastric cancerchemotherapyHuachansu capsule

韩雪静、施志杰、陶欢欢

展开 >

河南科技大学第一附属医院胃肠肿瘤外科,河南 洛阳 471000

晚期胃癌 化疗 华蟾素胶囊

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(23)